These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16762794)

  • 21. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
    Carrington M; Stewart S
    Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should we still prescribe digoxin in mild-to-moderate heart failure? Is quality of life the issue rather than quantity?
    Soler-Soler J; Permanyer-Miralda G
    Eur Heart J; 1998 Dec; 19 Suppl P():P26-31. PubMed ID: 9886709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
    Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
    Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.
    Masoudi FA; Baillie CA; Wang Y; Bradford WD; Steiner JF; Havranek EP; Foody JM; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(18):2069-76. PubMed ID: 16216996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of digoxin in heart failure. Should we bother?
    Frank J; Evans MF
    Can Fam Physician; 1997 Jul; 43():1227-8. PubMed ID: 9241459
    [No Abstract]   [Full Text] [Related]  

  • 30. Resource utilization in patients hospitalized with heart failure: insights from a contemporary national hospital database.
    Hauptman PJ; Swindle J; Burroughs TE; Schnitzler MA
    Am Heart J; 2008 Jun; 155(6):978-985.e1. PubMed ID: 18513507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digoxin therapy: A persisting interest despite contrary winds.
    Juillière Y; Selton-Suty C
    Arch Cardiovasc Dis; 2010 May; 103(5):281-4. PubMed ID: 20619237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Digoxin Benefit Varies by Risk of Heart Failure Hospitalization: Applying the Tufts MC HF Risk Model.
    Upshaw JN; van Klaveren D; Konstam MA; Kent DM
    Am J Med; 2018 Jun; 131(6):676-683.e2. PubMed ID: 29284111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of serum digoxin concentration and outcomes in patients with heart failure.
    Rathore SS; Curtis JP; Wang Y; Bristow MR; Krumholz HM
    JAMA; 2003 Feb; 289(7):871-8. PubMed ID: 12588271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial.
    Ahmed A; Rich MW; Love TE; Lloyd-Jones DM; Aban IB; Colucci WS; Adams KF; Gheorghiade M
    Eur Heart J; 2006 Jan; 27(2):178-86. PubMed ID: 16339157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions.
    Ambrosy AP; Butler J; Ahmed A; Vaduganathan M; van Veldhuisen DJ; Colucci WS; Gheorghiade M
    J Am Coll Cardiol; 2014 May; 63(18):1823-32. PubMed ID: 24613328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
    Anand IS; Carson P; Galle E; Song R; Boehmer J; Ghali JK; Jaski B; Lindenfeld J; O'Connor C; Steinberg JS; Leigh J; Yong P; Kosorok MR; Feldman AM; DeMets D; Bristow MR
    Circulation; 2009 Feb; 119(7):969-77. PubMed ID: 19204305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.
    Ahmed A; Rich MW; Fleg JL; Zile MR; Young JB; Kitzman DW; Love TE; Aronow WS; Adams KF; Gheorghiade M
    Circulation; 2006 Aug; 114(5):397-403. PubMed ID: 16864724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.